Blankenstein T - Search Results

1

Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine Repertoires.

Grunert C, Willimsky G, Peuker CA, Rhein S, Hansmann L, Blankenstein T, Blanc E, Beule D, Keller U, Pezzutto A, Busse A. Grunert C, et al. Among authors: blankenstein t. Cancers (Basel). 2022 Apr 6;14(7):1842. doi: 10.3390/cancers14071842. Cancers (Basel). 2022. PMID: 35406613 Free PMC article.

2

Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells.

Aicher A, Westermann J, Cayeux S, Willimsky G, Daemen K, Blankenstein T, Uckert W, Dörken B, Pezzutto A. Aicher A, et al. Among authors: blankenstein t. Exp Hematol. 1997 Jan;25(1):39-44. Exp Hematol. 1997. PMID: 8989905

3

Lack of correlation between rejection of tumor cells co-expressing interleukin-2 and B7.1 and vaccine efficiency.

Cayeux S, Richter G, Becker C, Beck C, Aicher A, Pezzutto A, Dörken B, Blankenstein T. Cayeux S, et al. Among authors: blankenstein t. Eur J Immunol. 1997 Jul;27(7):1657-62. doi: 10.1002/eji.1830270710. Eur J Immunol. 1997. PMID: 9247574

4

Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activation.

Westermann J, Aicher A, Qin Z, Cayeux Z, Daemen K, Blankenstein T, Dörken B, Pezzutto A. Westermann J, et al. Among authors: blankenstein t. Gene Ther. 1998 Feb;5(2):264-71. doi: 10.1038/sj.gt.3300568. Gene Ther. 1998. PMID: 9578847

5

RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes.

Uckert W, Willimsky G, Pedersen FS, Blankenstein T, Pedersen L. Uckert W, et al. Among authors: blankenstein t. Hum Gene Ther. 1998 Nov 20;9(17):2619-27. doi: 10.1089/hum.1998.9.17-2619. Hum Gene Ther. 1998. PMID: 9853528

6

Direct and indirect T cell priming by dendritic cell vaccines.

Cayeux S, Richter G, Becker C, Pezzutto A, Dörken B, Blankenstein T. Cayeux S, et al. Among authors: blankenstein t. Eur J Immunol. 1999 Jan;29(1):225-34. doi: 10.1002/(SICI)1521-4141(199901)29:01<225::AID-IMMU225>3.0.CO;2-W. Eur J Immunol. 1999. PMID: 9933104 Free article.

7

Retroviral B7.1 gene transfer in cancer cells protects cytotoxic T cells from deletion by "veto" apoptosis.

Daniel PT, Kroidl A, Cayeux S, Scholz C, Sturm I, Blankenstein T, Pezzutto A, Dörken B. Daniel PT, et al. Among authors: blankenstein t. Adv Exp Med Biol. 1998;451:265-76. doi: 10.1007/978-1-4615-5357-1_43. Adv Exp Med Biol. 1998. PMID: 10026884 No abstract available.

8

Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors.

Willimsky G, Blankenstein T. Willimsky G, et al. Among authors: blankenstein t. Cancer Res. 2000 Feb 1;60(3):685-92. Cancer Res. 2000. PMID: 10676654

9

Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia.

Westermann J, Kopp J, Körner I, Richter G, Qin Z, Blankenstein T, Dörken B, Pezzutto A. Westermann J, et al. Among authors: blankenstein t. Bone Marrow Transplant. 2000 May;25 Suppl 2:S46-9. doi: 10.1038/sj.bmt.1702354. Bone Marrow Transplant. 2000. PMID: 10933188

10

Allogeneic vaccination for renal cell carcinoma: development and monitoring.

Pohla H, Frankenberger B, Stadlbauer B, Oberneder R, Hofstetter A, Willimsky G, Pezzutto A, Dörken B, Blankenstein T, Schendel DJ. Pohla H, et al. Among authors: blankenstein t. Bone Marrow Transplant. 2000 May;25 Suppl 2:S83-7. doi: 10.1038/sj.bmt.1702362. Bone Marrow Transplant. 2000. PMID: 10933197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters